• Users Online: 1247
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 
This article has been cited by
1Real-life data on basal cell carcinoma treatment: Insights on clinicians' therapeutic choices from an institutional hospital registry
Sofia-Magdalini Manoli,Andreas Moutsoudis,Chryssoula Papageorgiou,Konstantinos Lallas,Haris-Marios Rigas,Eirini Kyrmanidou,Ilias Papadimitriou,Eleni Paschou,Ioannis Spyridis,Theodosia Gkentsidi,Elena Sotiriou,Efstratios Vakirlis,Demetrios Ioannidis,Zoe Apalla,Aimilios Lallas
Dermatologic Therapy.2020;33(6)
[DOI]
2Treatment of Pigmented Basal Cell Carcinoma with 3?mm Surgical Margin in Asians
Shang-Hung Lin,Yu-Wen Cheng,Yi-Chien Yang,Ji-Chen Ho,Chih-Hung Lee
BioMed Research International.2016;2016(6)1
[DOI]
3Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling
Yu-Wen Yeh,Ching-Chia Cheng,Shu-Ting Yang,Chi-Feng Tseng,Ting-Yu Chang,Sin-Ying Tsai,Earl Fu,Chien-Ping Chiang,Li-Chuan Liao,Pei-Wen Tsai,Yung-Luen Yu,Jen-Liang Su
Oncotarget.2017;8(3)5603
[DOI]
4Evaluation of the appropriate surgical margin for pigmented basal cell carcinoma according to the risk factors for recurrence: a single-institute retrospective study in Japan
Y. Nakamura,K. Tanese,I. Hirai,K. Kameyama,Y. Kawakami,M. Amagai,T. Funakoshi
Journal of the European Academy of Dermatology and Venereology.2018;32(12)e453
[DOI]
  Feedback
Advertise

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal